Clinical and Molecular Hepatology (Oct 2024)

Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis”

  • Tian-Yi Ren,
  • Mohammed Eslam,
  • Jian-Gao Fan

DOI
https://doi.org/10.3350/cmh.2024.0558
Journal volume & issue
Vol. 30, no. 4
pp. 649 – 652

Abstract

Read online

No abstracts available.

Keywords